89
Views
52
CrossRef citations to date
0
Altmetric
Research Article

Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate

Pages 575-580 | Published online: 08 Jul 2009
 

Abstract

Altered renal function is an essential component of the pathophysiological process in preeclampsia. The kidneys play a significant part in the turnover of most low molecular weight substances such as creatinine, urate and cystatin C. The present work was undertaken to investigate if the serum levels of these components are altered in characteristic ways in preeclampsia, and can be used to assist in the diagnosis of this condition. The serum levels were therefore determined in samples from 100 healthy women at term as well as in 45 samples of patients with preeclampsia (diastolic blood pressure > 90 mmHg; urinary albumin excretion > 300 mg L -1 ). The levels of all three components were significantly higher in samples from preeclamptic patients with the mean &#45 SD being 1.55 &#45 0.29 vs. 1.05 &#45 0.19 mg L -1 for cystatin C, 70 &#45 23 vs. 56 &#45 9.7 mumol L -1 for creatinine, and 413 &#45 128 vs. 305 &#45 61 mumol L -1 for urate. Receiver operating characteristic analysis demonstrated that the serum level of cystatin C had a superior diagnostic accuracy for preeclampsia compared to those of serum urate and creatinine and that the diagnostic accuracy of serum urate was better than that of serum creatinine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.